Ada Barnea

Israel Institute for Biological Research

Papers

1

Total Citations

27

H-Index

1

About

Dr. Ada Barnea is a leading researcher in the field of biodefense and neurotoxinology, with a primary focus on botulinum neurotoxins (BoNT)—among the most lethal substances known to humanity. Her work centers on developing advanced antibody-based countermeasures for botulism, a potentially fatal paralytic disease. In her highly cited 2014 study, "Evaluating the Synergistic Neutralizing Effect of Anti-Botulinum Oligoclonal Antibody Preparations," Dr. Barnea addressed a critical gap in treatment by exploring how engineered oligoclonal antibody cocktails could neutralize multiple BoNT serotypes, particularly A, B, and E, which cause most human cases. This research demonstrated that combining specific monoclonal antibodies could achieve synergistic neutralization, offering a more effective and safer alternative to traditional polyclonal antibodies used in detection and therapy. With 27 citations, this work has influenced subsequent efforts to design next-generation antitoxins. Dr. Barnea’s contributions are vital for improving public health preparedness against botulism outbreaks and bioterrorism threats, establishing her as a key figure in translational immunology and toxin research.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Evaluating the Synergistic Neutralizing Effect of Anti-Botulinum Oligoclonal Antibody Preparations
27 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Israel Institute for Biological Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago